U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240909) titled 'Antihypertensive Drug Selection Based on Hemodynamic Phenotypes' on Nov. 13.
Brief Summary: The goal of this clinical trial is to explore the clinical efficacy and safety of individualized antihypertensive medication guided by hemodynamic phenotyping. The main questions it aims to answer are:
1. Does hemodynamics-based individualized antihypertensive therapy achieve better blood pressure control compared to guideline-based conventional therapy?
2. Does hemodynamics-based individualized therapy have comparable safety to guideline-based conventional treatment? Researchers will compare hemodynamics-based individualized antihypertensi...